STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Profusa Stock Price, News & Analysis

PFSA NASDAQ

Company Description

Welcome to the overview page for Profusa (PFSA), where you can find comprehensive stock information and company updates.

Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.

Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.

Stock Performance

$—
0.00%
0.00
Last updated:
-91.24 %
Performance 1 year
$11.9M

Financial Highlights

$8,196,876
Net Income (TTM)
$501,614
Operating Cash Flow
Revenue (TTM)

Upcoming Events

JAN
01
January 1, 2026 - April 30, 2026 Product

Insight portal launch

Launch of AI-powered biochemistry monitoring portal across EEA under CE Mark
JAN
01
January 1, 2026 - March 31, 2026 Product

EU Lumee platform launch

Launch of Lumee tissue oxygen monitoring platform in Europe
MAR
31
March 31, 2026 Regulatory

CE GMED certification

Expected CE GMED certification for EU commercialization
APR
01
April 1, 2026 - June 30, 2026 Product

EU commercialization

Commercial launch of Lumee platform in EU market
APR
01
April 1, 2026 - June 30, 2026 Product

Begin product shipments

Start shipments and revenue for Lumee oxygen monitoring systems
MAY
01
May 1, 2026 - August 31, 2026 Regulatory

FDA submission for Lumee

U.S. FDA submission for Lumee tissue oxygen platform
JAN
01
January 1, 2027 - March 31, 2027 Product

US Lumee oxygen launch

Launch of Lumee oxygen biosensor in US
JAN
01
January 1, 2027 - December 31, 2027 Product

Lumee platform commercialization

Commercial launch of Lumee tissue oxygen monitoring platform in U.S.
MAY
01
May 1, 2027 - August 31, 2027 Product

EU Lumee glucose launch

Launch of Lumee glucose biosensor in EU market
MAY
01
May 1, 2027 - August 31, 2027 Product

Glucose platform commercialization

Commercialization of glucose monitoring platform

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Profusa (PFSA)?

The current stock price of Profusa (PFSA) is $0.177 as of December 5, 2025.

What is the market cap of Profusa (PFSA)?

The market cap of Profusa (PFSA) is approximately 11.9M. Learn more about what market capitalization means .

What is the net income of Profusa (PFSA)?

The trailing twelve months (TTM) net income of Profusa (PFSA) is $8,196,876.

What is the earnings per share (EPS) of Profusa (PFSA)?

The diluted earnings per share (EPS) of Profusa (PFSA) is $1.53 on a trailing twelve months (TTM) basis. Learn more about EPS .

What is the operating cash flow of Profusa (PFSA)?

The operating cash flow of Profusa (PFSA) is $501,614. Learn about cash flow.

What is the current ratio of Profusa (PFSA)?

The current ratio of Profusa (PFSA) is 0.04, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the operating income of Profusa (PFSA)?

The operating income of Profusa (PFSA) is $967,084. Learn about operating income.